Pharmicell is trading at 18,450 KRW as of 10:30 AM on the 13th, down 0.81% from the previous day. This represents an 11.08% decrease compared to September 10. Pharmicell is known as a bio-pharmaceutical company that developed the world's first stem cell therapy.


Today, foreigners are tentatively recorded as net sellers of 12,406 shares. Over the past five days, individual investors have been net buyers of 204,567 shares, while foreigners and institutions have been net sellers of 188,860 shares and net buyers of 23,203 shares, respectively.


On October 5, Pharmicell became a market issue with the headline 'Soars on news of President Trump's Remdesivir treatment.'




[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing